Literature DB >> 26036241

Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.

Dayue Darrel Duan1, Zhong Wang2, Bo-li Zhang3, Yong-yan Wang2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26036241      PMCID： PMC4594183          DOI： 10.1038/aps.2015.33

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  21 in total

Review 1.  Fangjiomics: in search of effective and safe combination therapies.

Authors:  Zhong Wang; Jun Liu; Yiyu Cheng; Yongyan Wang
Journal:  J Clin Pharmacol       Date:  2011-01-05       Impact factor: 3.126

2.  Navigating personalized medicine dependent on modular flexibility.

Authors:  Zhong Wang; Yongyan Wang
Journal:  Trends Mol Med       Date:  2013-05-24       Impact factor: 11.951

Review 3.  Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.

Authors:  R Kaddurah-Daouk; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2013-11-05       Impact factor: 6.875

Review 4.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 5.  Genetics of complex disease: approaches, problems, and solutions.

Authors:  N J Schork
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

Review 6.  Diverse array-designed modes of combination therapies in Fangjiomics.

Authors:  Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

Review 7.  Anticancer drugs: Finding the perfect combination.

Authors:  Alexandra Flemming
Journal:  Nat Rev Drug Discov       Date:  2015-01       Impact factor: 84.694

8.  Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway.

Authors:  Xin-yu Liu; Xin-yu Zhou; Jin-cai Hou; Hua Zhu; Zhong Wang; Jian-xun Liu; Yong-qiu Zheng
Journal:  Acta Pharmacol Sin       Date:  2015-03-16       Impact factor: 6.150

Review 9.  Anti-tumor activities of active ingredients in Compound Kushen Injection.

Authors:  Wei Wang; Rong-li You; Wen-jie Qin; Li-na Hai; Ming-jing Fang; Guo-hua Huang; Rui-xia Kang; Ming-hua Li; Yu-feng Qiao; Jian-wei Li; An-ping Li
Journal:  Acta Pharmacol Sin       Date:  2015-05-18       Impact factor: 6.150

10.  Phenome-wide association studies (PheWASs) for functional variants.

Authors:  Zhan Ye; John Mayer; Lynn Ivacic; Zhiyi Zhou; Min He; Steven J Schrodi; David Page; Murray H Brilliant; Scott J Hebbring
Journal:  Eur J Hum Genet       Date:  2014-07-30       Impact factor: 4.246
View more
  10 in total

1.  Duhuo Jisheng Decoction inhibits SDF-1-induced inflammation and matrix degradation in human degenerative nucleus pulposus cells in vitro through the CXCR4/NF-κB pathway.

Authors:  Zong-Chao Liu; Zhen-Long Wang; Chen-Yi Huang; Zhi-Jiang Fu; Yong Liu; Zhang-Chao Wei; Shi-Gui Liu; Chuan Ma; Jie-Liang Shen; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Yong-Yan Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06       Impact factor: 6.150

3.  Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels.

Authors:  Yan-Hong Luo; Min Zhu; Dong-Gang Wang; Yu-Sheng Yang; Tao Tan; Hua Zhu; Jian-Feng He
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

Review 4.  Full genetic analysis for genome-wide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine.

Authors:  Gang Chen; Wen-da Xue; Jun Zhu
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

5.  Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice.

Authors:  Peng-Qian Wang; Qiong Liu; Wen-Juan Xu; Ya-Nan Yu; Ying-Ying Zhang; Bing Li; Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2018-01-18       Impact factor: 6.150

6.  Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection.

Authors:  Ming Lyu; Chun-Lin Yan; Hai-Xin Liu; Tai-Yi Wang; Xin-Hui Shi; Jin-Ping Liu; John Orgah; Guan-Wei Fan; Ji-Hong Han; Xiao-Ying Wang; Yan Zhu
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

7.  A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling.

Authors:  Ying-Ying Zhang; Zi-de Zhao; Peng-Yun Kong; Lin Gao; Ya-Nan Yu; Jun Liu; Peng-Qian Wang; Bing Li; Xiao-Xu Zhang; Li-Qiang Yang; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2020-02-12       Impact factor: 6.150

8.  Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke.

Authors:  Pengqian Wang; Li Dai; Weiwei Zhou; Jing Meng; Miao Zhang; Yin Wu; Hairu Huo; Xingjiang Xiong; Feng Sui
Journal:  Front Pharmacol       Date:  2019-11-05       Impact factor: 5.810

9.  Integrated Pharmacogenetics Analysis of the Three Fangjis Decoctions for Treating Arrhythmias Based on Molecular Network Patterns.

Authors:  Penglu Wei; Dehuai Long; Yupei Tan; Wenlong Xing; Xiang Li; Kuo Yang; Hongxu Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-24

10.  Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat.

Authors:  Yu-Xiang Fei; Bo Zhao; Qi-Yang Yin; Yan-Ying Qiu; Guang-Hui Ren; Bo-Wen Wang; Ye-Fang Wang; Wei-Rong Fang; Yun-Man Li
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.